ACR Calculator - Albumin to Creatinine Ratio

What Is ACR (Albumin-to-Creatinine Ratio)?

The Albumin-to-Creatinine Ratio (ACR) is a urine test that measures the amount of albumin relative to the amount of creatinine in a urine sample. Albumin is a protein that is normally found in the blood and filtered by the kidneys. Healthy kidneys do not allow a significant amount of albumin to pass into the urine. When the kidneys are damaged, however, they begin to leak albumin into the urine, a condition known as albuminuria.

The ACR test is considered the gold standard for screening and monitoring kidney disease, particularly in people with diabetes or hypertension. By measuring the ratio of albumin to creatinine (rather than just albumin alone), the test accounts for differences in urine concentration, providing a more accurate and reliable snapshot of kidney health from a single spot urine sample.

An ACR result is expressed in milligrams of albumin per gram of creatinine (mg/g). The test can detect very small amounts of albumin in the urine long before other signs or symptoms of kidney disease appear, making it an essential early screening tool. Early detection of increased albumin in the urine can lead to earlier intervention and significantly improved outcomes for patients at risk of chronic kidney disease (CKD).

Why Test for ACR? Screening for Kidney Disease

Testing for ACR is critically important because kidney disease often develops silently, with no noticeable symptoms until the disease has progressed to an advanced stage. By the time patients feel unwell, substantial and often irreversible kidney damage may have already occurred. Regular ACR testing helps catch kidney problems early, when treatment is most effective.

The following groups of people should have regular ACR testing:

• People with diabetes (Type 1 and Type 2): Diabetes is the leading cause of chronic kidney disease worldwide. High blood sugar levels damage the tiny blood vessels in the kidneys over time. The American Diabetes Association recommends annual ACR testing for all adults with Type 2 diabetes and for those with Type 1 diabetes who have had the condition for five or more years.
• People with high blood pressure (hypertension): Hypertension is the second leading cause of CKD. Elevated blood pressure puts extra strain on the kidney's filtering units (glomeruli), leading to damage and albumin leakage.
• People with a family history of kidney disease: Genetic factors can increase kidney disease risk. Those with a parent, sibling, or close relative who has had kidney disease should be screened regularly.
• People with cardiovascular disease: Heart disease and kidney disease are closely linked. Albuminuria is itself a risk factor for cardiovascular events.
• People over the age of 60: Kidney function naturally declines with age, making regular screening increasingly important as people get older.
• People of certain ethnic backgrounds: Those of African, Hispanic, Asian, and Native American descent have a higher risk of developing kidney disease.

Beyond screening for kidney disease, the ACR test also serves as a predictor of cardiovascular risk. Research has shown that even mildly elevated levels of albumin in the urine are associated with an increased risk of heart attack, stroke, and other cardiovascular events, independent of other risk factors. This dual role makes ACR testing a valuable component of overall health assessment.

How to Collect a Urine Sample for ACR Testing

The ACR test requires a urine sample, and the most common approach is a simple spot urine test, which can be collected at any time of day. However, many healthcare providers prefer a first-morning urine sample because it is the most concentrated and provides the most reliable results. Here is what you need to know about sample collection:

• First-morning sample (preferred): Collect the first urine of the day immediately upon waking. This sample reflects overnight kidney function and minimizes the influence of physical activity, posture, and hydration levels on albumin excretion.
• Random spot sample: If a first-morning sample is not available, a random urine sample collected at any point during the day can also be used. While slightly less accurate, this is often more practical in clinical settings and still provides useful diagnostic information.
• 24-hour urine collection: In some cases, a healthcare provider may request a full 24-hour urine collection for a more comprehensive assessment. This involves collecting all urine produced over a 24-hour period in a special container provided by the laboratory.

Factors that can temporarily increase albumin in the urine and may affect test accuracy include vigorous exercise within the preceding 24 hours, urinary tract infections, fever, menstruation, dehydration, and very high protein intake. It is generally recommended to avoid strenuous exercise before the test and to inform your healthcare provider of any conditions that might influence the results. If an initial test shows elevated ACR, a confirmatory repeat test is typically performed within three to six months before a definitive diagnosis is made.

Understanding Albumin in Urine

Albumin is the most abundant protein in the blood, produced by the liver and serving several essential functions. It helps maintain the oncotic pressure needed to distribute fluids properly between blood vessels and body tissues, transports hormones, vitamins, and medications through the bloodstream, and serves as a reserve of amino acids for the body.

Under normal conditions, the kidneys filter the blood and retain albumin, allowing only a tiny amount to pass into the urine. Each kidney contains approximately one million nephrons, which are the microscopic filtering units. Each nephron includes a glomerulus, a cluster of tiny blood vessels where filtration occurs. The glomerular filtration barrier is designed to prevent large proteins like albumin from passing through while allowing waste products and excess water to be excreted as urine.

When the glomeruli are damaged, whether by diabetes, high blood pressure, inflammation, or other causes, the filtration barrier becomes leaky and allows albumin to escape into the urine. The more damage there is, the more albumin leaks through. This is why measuring albumin in the urine is such an effective indicator of kidney health: it directly reflects the structural integrity of the glomerular filtration barrier.

The reason the test measures the ratio of albumin to creatinine (rather than albumin alone) is that the concentration of substances in urine varies depending on how diluted or concentrated the urine is. Creatinine, a waste product from muscle metabolism, is excreted at a relatively constant rate throughout the day. By dividing the albumin concentration by the creatinine concentration, the ACR effectively normalizes the result, accounting for differences in urine concentration and providing a consistent, comparable measurement.

ACR Categories Explained: A1, A2, and A3

The Kidney Disease Improving Global Outcomes (KDIGO) guidelines classify albuminuria into three categories based on the ACR value. These categories are used to assess the severity of albumin leakage, guide treatment decisions, and determine the overall risk of kidney disease progression and cardiovascular events.

Category A1: Normal to Mildly Increased (ACR less than 30 mg/g)

An ACR below 30 mg/g (or less than 3 mg/mmol) is considered normal to mildly increased. This indicates that the kidneys are functioning properly and filtering albumin effectively. Most healthy individuals fall into this category. Even within this range, however, values at the higher end (20-29 mg/g) in patients with diabetes may warrant closer monitoring, as they could represent the early beginnings of kidney changes. Patients in category A1 are at the lowest risk for CKD progression and cardiovascular events related to albuminuria.

Category A2: Moderately Increased (ACR 30 to 300 mg/g)

An ACR between 30 and 300 mg/g (3 to 30 mg/mmol) indicates moderately increased albumin in the urine. This stage was formerly referred to as "microalbuminuria," although this term is now less commonly used in clinical guidelines. Category A2 represents a clinically significant finding because it often marks the earliest detectable stage of kidney damage. In patients with diabetes, reaching A2 status is a strong predictor that kidney disease will progress if left untreated. Treatment at this stage often includes tighter blood sugar and blood pressure control, the use of ACE inhibitors or ARBs (medications that protect the kidneys), and lifestyle modifications. Early intervention at this stage can slow or even reverse kidney damage.

Category A3: Severely Increased (ACR greater than 300 mg/g)

An ACR above 300 mg/g (greater than 30 mg/mmol) indicates severely increased albumin excretion, formerly called "macroalbuminuria" or overt proteinuria. This level of albumin in the urine signifies substantial kidney damage. Patients in category A3 are at high risk for progressive kidney disease, potential kidney failure, and significant cardiovascular events. Aggressive treatment is typically necessary, including optimized blood pressure management, maximal doses of kidney-protective medications, dietary modifications (often a reduced protein or sodium diet), and close nephrological follow-up. Some patients may eventually require dialysis or kidney transplantation if the disease progresses despite treatment.

Category	ACR (mg/g)	ACR (mg/mmol)	Description
A1	< 30	< 3	Normal to mildly increased
A2	30 – 300	3 – 30	Moderately increased (microalbuminuria)
A3	> 300	> 30	Severely increased (macroalbuminuria)

CKD Stages Explained: G1 Through G5

Chronic Kidney Disease (CKD) is staged based on the estimated Glomerular Filtration Rate (eGFR), which measures how well the kidneys are filtering waste from the blood. The eGFR is expressed in milliliters per minute per 1.73 square meters of body surface area (mL/min/1.73m²). A higher eGFR indicates better kidney function. The KDIGO classification system defines six GFR stages:

GFR Stage	eGFR (mL/min/1.73m²)	Description
G1	≥ 90	Normal or high kidney function
G2	60 – 89	Mildly decreased kidney function
G3a	45 – 59	Mildly to moderately decreased kidney function
G3b	30 – 44	Moderately to severely decreased kidney function
G4	15 – 29	Severely decreased kidney function
G5	< 15	Kidney failure (may require dialysis or transplant)

It is important to note that GFR stages G1 and G2 alone do not constitute CKD unless there is also evidence of kidney damage, such as albuminuria (A2 or A3), structural abnormalities, or other markers of injury. A person with a normal eGFR but elevated ACR still has CKD. Conversely, mild reductions in eGFR (Stage G2) are common in older adults and may not indicate disease if there are no other signs of kidney damage.

The Combined CKD Staging System

Modern CKD classification combines both GFR stages (G1-G5) and albuminuria categories (A1-A3) to provide a comprehensive assessment of kidney disease severity and the risk of adverse outcomes. This two-dimensional classification system, established by KDIGO in 2012 and updated since, recognizes that both kidney function (eGFR) and kidney damage (albuminuria) independently contribute to patient prognosis.

The combined stage is expressed as a GFR stage followed by an albuminuria category, for example "G2/A2" or "G3a/A1." The CKD risk heat map (shown in the calculator above) visually represents the risk associated with each combination, using a color-coded system ranging from green (low risk) through yellow, orange, and red (very high risk).

Key principles of the combined staging system:

• Low risk (green): G1/A1 and G2/A1. These combinations may not meet the criteria for CKD unless there is other evidence of kidney damage. Routine monitoring is sufficient.
• Moderately increased risk (yellow): G1/A2, G2/A2, and G3a/A1. These warrant closer monitoring, typically every 6 to 12 months, and may require initiation of kidney-protective therapies.
• High risk (orange): G1/A3, G2/A3, G3a/A2, G3b/A1. These require active treatment and monitoring every 3 to 6 months. Referral to a nephrologist should be considered.
• Very high risk (red): G3a/A3, G3b/A2, G3b/A3, G4 (all categories), and G5 (all categories). These require nephrology referral, aggressive management, and close follow-up every 1 to 3 months. Preparation for renal replacement therapy may be necessary at stages G4 and G5.

How to Calculate ACR: Step by Step with Example

Calculating the Albumin-to-Creatinine Ratio involves dividing the albumin concentration in the urine by the creatinine concentration, after converting both values to consistent units. Here is a detailed, step-by-step walkthrough:

Step 1: Obtain Your Lab Values

From your urine test results, note the albumin concentration and the creatinine concentration along with their respective units. For this example, let us assume:

• Urine Albumin: 10 mg/dL
• Urine Creatinine: 150 mg/dL

Step 2: Convert Units

The ACR formula requires albumin in milligrams (mg) and creatinine in grams (g) to produce a result in mg/g. If your values are in mg/dL, convert creatinine from mg/dL to g/dL by dividing by 1000:

Step 3: Calculate the Ratio

Divide albumin (mg/dL) by creatinine (g/dL):

Step 4: Interpret the Result

An ACR of 66.7 mg/g falls into Category A2 (Moderately Increased), since it is between 30 and 300 mg/g. This indicates that the kidneys are leaking more albumin than normal and warrants medical follow-up.

Common Unit Conversions

From	To	Multiply By
mg/L (albumin)	mg/dL	0.1
mg/dL (creatinine)	g/dL	0.001
g/dL (creatinine)	mg/dL	1000
mmol/L (creatinine)	g/dL	0.0113
mg/g (ACR)	mg/mmol	0.113

When to See a Doctor

You should consult a healthcare provider about your ACR results in the following situations:

• Your ACR is 30 mg/g or higher (A2 or A3): Any result in the moderately or severely increased range requires medical evaluation. Your doctor will likely order repeat testing to confirm the result and may perform additional tests to determine the cause of the albuminuria.
• You have diabetes and any elevated ACR: Even values at the upper end of the normal range in diabetic patients may prompt your doctor to start or adjust kidney-protective medications.
• You notice changes in urination: Foamy or frothy urine, changes in urine color, increased frequency of urination (especially at night), or decreased urine output can be signs of kidney problems.
• You experience unexplained swelling: Edema (swelling) in the legs, ankles, feet, face, or hands can indicate that the kidneys are not properly managing fluid balance.
• You have persistent fatigue, nausea, or loss of appetite: These can be symptoms of advanced kidney dysfunction and the buildup of waste products in the blood (uremia).
• Your eGFR is below 60 mL/min/1.73m²: Regardless of ACR, a significantly reduced eGFR warrants medical attention and ongoing monitoring.

Remember that a single elevated ACR result does not necessarily confirm kidney disease. Transient factors like intense exercise, urinary infections, or dehydration can temporarily raise albumin levels. Your doctor will typically confirm an abnormal result with at least one additional test, performed on a separate occasion, before making a diagnosis. If kidney disease is confirmed, early and consistent treatment can dramatically slow its progression and protect your overall health.

Frequently Asked Questions (FAQ)